期刊文献+

Avastin对神经母细胞瘤株SK-N-SH增殖影响的体外研究 被引量:1

Effect of avastin on neuroblastoma SK-N-SH cell proliferation
原文传递
导出
摘要 目的以人神经母细胞瘤SK-N-SH细胞株为研究对象探讨Avastin对其增殖的影响及可能机制。方法测定不同Avastin浓度对SK-N-SH细胞上清液VEGF水平的影响,对该株细胞的细胞毒作用及对其细胞周期及凋亡的影响。结果随着Avastin浓度升高,细胞上清液中游离VEGF水平逐渐下降;在一定剂量范围内,Avastin对该株细胞无明显细胞毒性作用;不同浓度Avastin作用于该株细胞,呈时间依赖性,影响细胞周期分布。结论Avastin可中和SK-N-SH细胞分泌的VEGF,无明显细胞毒性作用,但可影响细胞周期分布,提示Avastin与化疗药物联合应用可能有协同作用。 Objective Vascular endothelial growth factor (VEGF) is associated with tumor growth and metastasis and is over-expressed in neuroblastoma. Avastin is the monoclonal antibody of VEGF and can inhibit tumor growth by blocking the VEGF signaling pathway. However, the mechanism remains unclear. The current study aims to assess the effect of Avastin on proliferation of human NB SK-N-SH cells. Methods ELISA was used to assay the expression of VEGF in supernatant of SK-N-SH cells. MTT assay was used to measure Avastin-induced cytotoxicity in SK-N-SH cells. Flow cytometry was used to detect the effect of Avastin on cell cycle and apoptosis. Results Avastin could neutralize VEGF and gradually decreased the level of VEGF in supernatant in SK-N-SH cells at increased concentrations. The level of VEGF was reduced to 0 μg/ml by Avastin at 50 μg/ml. Avastin did not induce cytotoxicity in SK-N-SH cells at 0. 5 μg/ml-50 μg/ml. Avastin at different concentrations induced cell cycle redistribution in a time-dependent manner. Avastin decreased the fraction of cells in G0-G1 phase and increased that in S phase at 5 μg/ml and 10 μg/ml. It also induced apoptosis at 50 μg/ml. Conclusions Avastin could neutralize the secreted VEGF, redistributes cells from G0-G1 phase to S phase and induces apoptosis in SK-N-SH cells. Avastin may be used as adjunct to chemotherapy of neuroblastoma.
出处 《中华小儿外科杂志》 CSCD 北大核心 2008年第2期110-113,共4页 Chinese Journal of Pediatric Surgery
关键词 神经母细胞瘤 血管内皮细胞生长因子 细胞增殖 Neuroblastoma Vascular endothelial growth factor Cell proliferation
  • 相关文献

参考文献10

  • 1Cotterill SJ, Pearson AD, Pritchard J, et al. Clinical prognostic factors in 1277 patients with neuroblastoma: Results of the european neuroblastoma study group survey: 1982-1992. Eur J Cancer, 2000, 36: 901-908. 被引量:1
  • 2Ribatti D, Vacca A, Nico B, et al. Angiogenesis and anti-angiogenesis in neuroblastoma. Eur J Cancer, 2002,38:750-757. 被引量:1
  • 3王智辉,孙晓非,甄子俊,夏奕,凌家瑜.晚期神经母细胞瘤患者血清VEGF水平的临床意义[J].中国肿瘤,2006,15(5):322-324. 被引量:2
  • 4Wang Y, Fei D, Vanderlaan M, et al. Biological activity of bevacizumab, a human anti-VEGF antibody in vitro. Angiogcncsis, 2004,7 : 335-345. 被引量:1
  • 5Byrne AM, Bouehier-Hayes DJ, Harrney JH. Angiogenie and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med, 2005, 9:777-794. 被引量:1
  • 6Beierle EA, Strande LF, Chen MK. VEGF upregulates Bcl-2 expression and is associated with deceased apoptosis in neuroblasto ma cells. J Pediatr Surg,2002,37: 467-471. 被引量:1
  • 7Mercurio AM, Bachelder RE, Bates RC, et al. Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin. Semin Cancer Biol, 2004, 14: 115-122. 被引量:1
  • 8Ferrara N, Hillan K J, Novomv W. Bevaeizumab (Avastin), a humanized anti-VEGF monoelonal antibody for eaneer therapy. Bioehem Biophys Res Commun, 2005, 333: 328-335. 被引量:1
  • 9Meister B, Grunebach F, Bautz F, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neurohlastoma. Eur J Cancer, 1999,35:445-449. 被引量:1
  • 10Seqerstrom L, Fuchs D, Backman U, et al. The anti VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts. Pediatr Res, 2006, 60: 576-581. 被引量:1

二级参考文献9

  • 1Meister B,Grunebach F,Bautz F,et al.Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma[J].Eur J Cancer,1999,35(3):445-449. 被引量:1
  • 2Fakhari M,Pullirsch D,Paya K,et al.Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma[J].J Pediatr Surg,2002,37(4):582-587. 被引量:1
  • 3Dvorak HF.Vascular permeability factor/vascular endothelial growth factor:A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy[J].J Clin Oncol,2002,20(21):4368-4380. 被引量:1
  • 4Eggert A,Ikegaki N,Kwiatkowski J,et al.High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas[J].Clin Cancer Res,2000,6(5):1900-1908. 被引量:1
  • 5Fukuzawa M,Sugiura H,Koshinaga T,et al.Expression of vascular endothelial growth factor and its receptor flk-1 in human neuroblastoma using in situ hybridization[J].J Pediatr Surg,2002,37(12):1747-1750. 被引量:1
  • 6Pavlakovic H,Von Schutz V,Rossler J,et al.Quantification of angiogenesis stimulators in children with solid malignancies[J].Int J Cancer,2001,92(5):756-760. 被引量:1
  • 7El-Houseini ME,Abdel-Azim SA,E1-Desouky GI,et al.Clinical significance of vascular endothelial growth factor(VEGF) in sera of patients with pediatric malignancies[J].J Egypt Natl Canc Inst,2004,16(1):57-61. 被引量:1
  • 8Langer I,Vertongen P,Perret J,et al.Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas[J].Med Pediatr Oncol,2000,34(6):386-393. 被引量:1
  • 9Tabone MD,Landman-Parker J,Areil B,et al.Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?[J].Clin Cancer Res,2001,7(3):538-543. 被引量:1

共引文献1

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部